📰 FTC TARGETS PATENT LISTINGS ON OZEMPIC, OTHER DRUGS, SOURCES SAY — WSJ FTC MOVES MOVES AN EFFORT TO HELP SMOOTH TRANSITION TO MORE AFFORDABLE DRUGS, SOURCES SAY — WSJ FTC SEES DRUGMAKERS’ PATENT EFFORTS AS ATTEMPT TO DELAY COMPETITION FROM GENERIC DRUGS, SOURCES SAY — WSJ

FTC TARGETS PATENT LISTINGS ON OZEMPIC, OTHER DRUGS, SOURCES SAY — WSJ

FTC MOVES MOVES AN EFFORT TO HELP SMOOTH TRANSITION TO MORE AFFORDABLE DRUGS, SOURCES SAY — WSJ

FTC SEES DRUGMAKERS’ PATENT EFFORTS AS ATTEMPT TO DELAY COMPETITION FROM GENERIC DRUGS, SOURCES SAY — WSJ